Biotech

All Articles

BioMarin halts preclinical gene therapy for heart condition

.After BioMarin performed a spring clean of its own pipeline in April, the company has determined th...

Eisai vegetations molecular glue SEED with $1.5 B biobucks handle

.Big Pharmas remain stuck to the tip of molecular adhesive degraders. The most up to date company to...

Life scientific research debt organization unveils with $600M

.A brand new worldwide life science credit rating company, termed Symbiotic Financing, has actually ...

BMS channels TIGIT, walking away from $200M bet on Agenus bispecific

.Bristol Myers Squibb is axing an additional large bet from the Caforio time, ending a deal for Agen...

Nuvation stops wager prevention after thinking about phase 1 information

.After looking at phase 1 data, Nuvation Bio has chosen to stop focus on its one-time lead BD2-selec...

' Scientific intuitiveness' led FDA consultants to support Zevra's rare illness med

.Zevra Therapeutics' uncommon condition medicine appears to become on the pathway to approval this l...

Pfizer takes $230M hit after axing neglected DMD gene treatment

.Pfizer's stage 3 Duchenne muscle dystrophy (DMD) gene treatment breakdown has actually blown a $230...

AC Immune observes 'site' possible in Alzheimer's medicine records

.After greater than two decades of service neurodegenerative illness, Swiss biotech air conditioning...

GSK falls ph. 2 HPV injection over lack of best-in-class prospective

.GSK has broken up a phase 2 individual papillomavirus (HPV) injection from its own pipeline after d...

OS Treatments refiles $6M IPO to finance HER2 medication, preclinical ADCs

.Operating system Therapies will certainly note on the NYSE American stock swap this morning via a $...